Page last updated: 2024-08-24

capecitabine and Acquired Autoimmune Hemolytic Anemia

capecitabine has been researched along with Acquired Autoimmune Hemolytic Anemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, H; Hara, K; Higuchi, K; Hijioka, S; Kawai, H; Kondo, S; Mizuno, N; Nakamura, M; Niwa, Y; Ogura, T; Sawaki, A; Tajika, M; Yamao, K1
Imai, E; Ito, I; Ito, Y; Kosugi, T; Maruyama, S; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Suzuki, Y; Tsuboi, N; Yasuda, K; Yasuda, Y1
Chen, VM; Flower, RL; Jackson, D; Morel-Kopp, MC; Thrift, KM; Ward, CM1

Reviews

1 review(s) available for capecitabine and Acquired Autoimmune Hemolytic Anemia

ArticleYear
[Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:10

    Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Recurrence

2011

Other Studies

2 other study(ies) available for capecitabine and Acquired Autoimmune Hemolytic Anemia

ArticleYear
A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:3

    Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prednisone; Thrombocytopenia

2012
An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
    Transfusion, 2004, Volume: 44, Issue:6

    Topics: Adenocarcinoma; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Antigens; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Grouping and Crossmatching; Blood Transfusion; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dexamethasone; Disease Progression; Fatal Outcome; Female; Fluorouracil; Humans; Immunoglobulin G; Irinotecan; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin

2004